The ability of acrylamide to cause cancer tumor-forming mutations in human and laboratory animal cells is based on the capacity of its primary metabolite, called glycidamide, to bind to DNA, City of Hope Cancer Center researchers report. more…

http://www.charitypartnership.com/resources/center-for-effective-philanthropy.html
Originally Posted on 2/7/2006 9:01:29 PM
Content source: http://www.charitywire.com/charity45/05817.html